Abdominal #33

33-year-old-male-patient:

    • Presented with jaundice
    • laboratory tests revealed elevated levels of serum alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin, and direct bilirubin

What do you see?
    • A lobulated mass within the bile ducts (shown in red areas)
    • Dilatation of intrahepatic bile ducts
    • A 3.5-cm-lobulated mass within the bile ducts (red arrows) with
      upstream and downstream dilatation of bile ducts
What is your diagnosis?
    • Intraductal papillary neoplasm of the bile duct (IPNB) with invasive carcinoma
    • In our case, the patient underwent surgery and the diagnosis was histopathologically confirmed
Teaching points
    • IPNBs are premalignant biliary epithelial tumors.
    • IPNBs originate from and communicate with the biliary tree and can occur anywhere along the biliary tree.
    • 30-40% of IPNBs exhibit mucin hypersecretion.
    • When symptomatic, patients present with recurrent abdominal pain, cholangitis, and jaundice.
    • Risk factors for IPNBs include hepatolithiasis, clonorchiasis, primary sclerosing cholangitis, biliary tree malformations, choledochal cysts, and familial adenomatous polyposis.
    • IPNB is analogous to the intraductal papillary mucinous neoplasm of the pancreas (IPMN).
    • Imaging findings of IPNB include:
        • Intraductal mass with upstream and downstream dilatation
        • Complex cystic mass with biliary ductal dilatation
        • Ductal dilatation without a mass, with associated parenchymal atrophy
        • Thread sign at MRCP (linear and curved filling defects due to mucin)
    • IPNBs may be associated with invasive carcinoma (27-94%)
    • Imaging findings that suggest invasive carcinoma at MRI include
        • A visible intraductal mass
        • Tumor size greater than 2.5 cm
        • Tumor multiplicity
        • Ductal wall thickening
        • Adjacent hepatic invasion
    • Early surgical intervention is the key management for IPNB.
    • All patients with IPNB should be considered for treatment, given the high potential for malignancy and for recurrent cholangitis and obstructive jaundice in nonmalignant cases

One thought on “Abdominal #33

Leave a Reply